Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
Brobert G, Ruigomez A, Schink T, Voss A, Herings R, Smits E, Swart KMA, Friberg L, Balabanova Y, Tarenz C, Suzart-Woischnik K, Soriano-Gabarró M, Vora P, Homering M, Dyszynski T, Nagel G, Amaya P, García Rodríguez LA.
Brobert G, et al. Among authors: soriano gabarro m.
BMJ Open. 2024 Mar 25;14(3):e081348. doi: 10.1136/bmjopen-2023-081348.
BMJ Open. 2024.
PMID: 38531587
Free PMC article.
Review.